ENDRA Life Sciences
NDRA
6 hedge funds and large institutions have $1.87M invested in ENDRA Life Sciences in 2019 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 3 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
0% less ownership
Funds ownership: 0% → 0% (-0%)
1% less capital invested
Capital invested by funds: $1.89M → $1.87M (-$22K)
33% less funds holding
Funds holding: 9 → 6 (-3)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$50.5K |
| 2 |
IAM
ICM Asset Management
Spokane,
Washington
|
+$50.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$50.5K |
| 2 |
VF
Virtu Financial
New York
|
-$47K |
| 3 |
SWM
SeaCrest Wealth Management
Purchase,
New York
|
-$32K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$29K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$22K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
IAM
1
ICM Asset Management
Spokane,
Washington
| $1.19M | +$50.5K | +1 | +5% |
|
|
2
Vanguard Group
Malvern,
Pennsylvania
| $359K | -$50.5K | -1 | -14% |
|
|
3
Geode Capital Management
Boston,
Massachusetts
| $107K | +$50.5K | +1 | +100% |
|
4
Creative Planning
Overland Park,
Kansas
| $68K | – | – | – |
|
|
BRWA
5
B. Riley Wealth Advisors
Boca Raton,
Florida
| $40K | – | – | – |
|
|
WEC
6
Winslow Evans & Crocker
Boston,
Massachusetts
| $36K | – | – | – |
|
7
Fidelity Investments
Boston,
Massachusetts
| $28K | – | – | – |
|
8
Northern Trust
Chicago,
Illinois
| $27K | – | – | – |
|
9
Morgan Stanley
New York
| $5K | – | – | – |
|
10
Royal Bank of Canada
Toronto,
Ontario, Canada
| $5K | – | – | – |
|
|
11
Citadel Advisors
Miami,
Florida
| – | -$29K | -1 | Closed |
|
|
SWM
12
SeaCrest Wealth Management
Purchase,
New York
| – | -$32K | -1 | Closed |
|
|
VF
13
Virtu Financial
New York
| – | -$47K | -1 | Closed |
|
|
TSS
14
Two Sigma Securities
New York
| – | -$22K | – | – |
|
15
UBS Group
Zurich,
Switzerland
| – | -$3K | – | – |
|
NDRA Hedge Fund Activity: Q2 2019 in Review
6 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in ENDRA Life Sciences (NDRA) for Q2 2019, worth a combined $1.87M — down 1.2% from $1.89M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of NDRA and 0 opened new positions — a net loss of 3 holders — while 1 trimmed existing stakes and 2 added.
The largest buyer was Geode Capital Management, adding an estimated $50.5K. The largest seller was Vanguard Group, cutting an estimated $50.5K.
- 6 institutional investors held ENDRA Life Sciences (NDRA) as of Q2 2019, down from 9 in Q1 2019.
- Funds reported $1.87M of ENDRA Life Sciences stock for Q2 2019, down 1.2% quarter-over-quarter.
- 0 funds opened new ENDRA Life Sciences positions in Q2 2019 and 3 closed out, a net change of -3 holders.
- The largest ENDRA Life Sciences buyer in Q2 2019 was Geode Capital Management, an estimated $50.5K added.
- The largest ENDRA Life Sciences seller in Q2 2019 was Vanguard Group, an estimated $50.5K sold.
Based on aggregated 13F filings for Q2 2019.